Asahi Kasei Establishes Asahi Kasei Life Science to Focus on Bioprocessing
Asahi Kasei Life Science expects to offer the bioindustry more agile and focused services and deeper innovation in bioprocess solutions.
Related Articles
The Body’s Delta Force: Natural Killer Cells Re-Emerge
Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and autoimmunity.
NSF starts to kill grants that violate Trump’s war on diversity efforts
Attracting women and minorities into science and studying misinformation are no longer priorities, agency says
Leidos, University of Pittsburgh spend $10M for AI disease detection
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.
Trump proposes massive NIH budget cut and reorganization
Will Republican-led Congress support a 44% decrease for world’s largest medical research funder?
U.S. climate data websites go dark
Lapse may be temporary, but draft budget plans would eliminate service
Trump administration targets academic journals with attorney letter, proposed funding cuts
Budget plan would kill two CDC journals, while U.S. prosecutor accuses some nongovernmental publications of being “partisans”
Colossal squid filmed in its natural habitat for the first time
The enigmatic predator, the heaviest known invertebrate, had never been seen alive in deep water
NIH freezes funds to Harvard and four other universities, but can’t tell them
Move follows broader White House attack on Harvard funding and stop-work orders to contractors
Exploring the Mutational Landscape of Colorectal Cancer
The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on genetic mutations.
AI Model Passed an Authentic Turing Test for the First Time
OpenAI’s latest LLM GPT-4.5 just became the first AI model to ever pass the Turing Test, but is it a fluke or the real deal?
